Diagnosis and Treatment of latent tuberculosis infection in adults in South Korea |
Kyung-Wook Jo1, Young Soon Yoon2, Hyung Woo Kim3, Joong-Yub Kim4, Young Ae Kang5, on behalf of the Korean TB guideline development committee |
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea 2Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang-si, Republic of Korea 3Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea 4Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea 5Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea |
Correspondence:
Young Ae Kang, Tel: 82-2-2228-, Fax: 82-2-2228-, Email: mdkang@yuhs.ac |
Received: 19 August 2024 • Revised: 20 September 2024 • Accepted: 30 September 2024 *Kyung-Wook Jo and Young Soon Yoon contributed equally to this study as co-first authors. |
Abstract |
Latent tuberculosis infection (LTBI) is characterized by immune responses to Mycobacterium tuberculosis antigens without clinical symptoms or evidence of active tuberculosis. Effective LTBI management is crucial for tuberculosis elimination, requiring accurate diagnosis and treatment. In South Korea, LTBI guidelines have been updated periodically, with the latest in 2024. This review discusses the recent changes in the Korean guideline for the diagnosis and treatment of LTBI in adults. |
Key Words:
latent tuberculosis infection, diagnosis, treatment, guideline |
|